{"id":882133,"date":"2025-09-04T16:30:45","date_gmt":"2025-09-04T20:30:45","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-september-investor-conferences\/"},"modified":"2025-09-04T16:30:45","modified_gmt":"2025-09-04T20:30:45","slug":"praxis-precision-medicines-to-participate-in-september-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-september-investor-conferences\/","title":{"rendered":"Praxis Precision Medicines to Participate in September Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BOSTON, Mass., Sept.  04, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jBu8d4ikAF9C4ESv6Ls18qS9qEAeY0EV2xuEOri3cE3_w_Pt3oZ-0tZMFXELMFkgwg_Yo0NHRFnSklikanNNiazO8Qh1HNlvAeB4boIl0Rx1BaN_WcArwaaMtSWnUprI\" rel=\"nofollow\" target=\"_blank\"><u>Praxis Precision Medicines<\/u><\/a>, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that Praxis\u2019 management will be attending and presenting in three upcoming investor conferences:<\/p>\n<ul>\n<li>Baird 2025 Global Healthcare Conference: a corporate presentation will take place on Tuesday, September 9th at 9:00-9:35am EDT at the InterContinental New York Barclay.<\/li>\n<li>H.C. Wainwright 27th Annual Global Investment Conference: a fireside chat will be held on Wednesday, September 10th at 8:30am EDT at the Lotte New York Palace Hotel in New York City. A live webcast of the fireside chat will be available through this <a href=\"https:\/\/journey.ct.events\/view\/247292b9-061a-4af8-a7bd-0e4e660b805f\" rel=\"nofollow\" target=\"_blank\">link<\/a>.<\/li>\n<li>TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry &amp; Epilepsy Summit: a corporate presentation will take place virtually on Thursday, September 18th at 3:00-3:30pm EDT.<\/li>\n<\/ul>\n<p>The Company will be available for one-on-one meetings during all events. Interested investors should contact their respective representatives to request meetings.<\/p>\n<p>A replay of the webcasted event will also be available through the \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=piNZFRR0eUWF0851h3B_O9tocPES5j404PNozFLJdpkCsUNgVg4hkNuf4CuMJSheyZkl7GzSpkoxO_VUgD9KCDviNlatKHKg6rUCu6Mqc-pzeyAX2ppqAgswTNwpuejf1C9fajS-t1L-SSFlsvm3s9VPKCi6-GgCyWlN9L148h0=\" rel=\"nofollow\" target=\"_blank\">Events &amp; Presentations<\/a>\u201d page under the \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PIGb5c3QUtqv1jSKD0Ve5n_Sep4IuAELh5t9_ouUimOcEfcXMqEdXZF8VI44n7_KCaupz-noQMcx8xMCbZRIphgBwb6wFj8fqAtyrsmdZzM=\" rel=\"nofollow\" target=\"_blank\">Investors + Media<\/a>\u201d section of the company\u2019s website for 90 days.<\/p>\n<p>\n        <strong>About Praxis\u202f\u00a0<\/strong><br \/>\n        <br \/>Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating insights from genetic epilepsies into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. Praxis is applying genetic insights to the discovery and development of therapies for rare and more prevalent neurological disorders through our proprietary small molecule platform, Cerebrum\u2122, and antisense oligonucleotide (ASO) platform, Solidus\u2122, using our understanding of shared biological targets and circuits in the brain. Praxis has established a diversified, multimodal CNS portfolio including multiple programs across epilepsy and movement disorders, with four clinical-stage product candidates. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XM4lnsGcaXRiv20-5ot0TlyZnwyy13qnYDzeJQ56RiRciLsupDOEd4WJVenb5G4hEUMOSYhPgxP4dUxOOCVlCexWiDLZ4RBMr0eYqYL0WHsEulx_fut-JhWmYeCEmEwhEFCTHOJYLaShb9yh0DVKJwCzPP0a-Ke2vFRtC1ZHJPeiIG6S4BCJUKdHJVpAay1_sJrvC2cnFvacQIHQFN0TUqK60Wxz3rW1SrhDDlGQcqv9WKdP4lGM2z0RuuWfPnQQFf4Va6XzyqMd1W_mBuPSL_9rs0ixZsKfM4Dc_VvDNUooj8L0cyLXLcdUVaehQ0-NO56jLJTlNArULUoKlC9MqpPJw5NBbyDFe0ZayeSjlGOdD_062olOQjoVFGIuDaVVTzSJNMqd4u2KRwyLbAKvJh3dap0bfT3ifS-IvWM8Ae3mXXlTAcVkZLlSCbQTbs6fFLTqeq2nDO-9UIQ9bSnlxHGcw9D5AvL7JNyvoOuKo-z7Cq1bEe_EyS9dqZ18UKi2I53x1xzQVXmMrJ1EWocA2_Z-Y2pNSy5MHStSJaXThAVkVDl9IKqeXM3odo1Y_SFuj7gL0ylXnVsp-DuaNxZEHijIqB4CKB4txbvpd8qi4YXQnUPvwq5pmv8byQDLZaQ9gNqCQb0skavTc5powKB-6YrRVnyn1NeqWVJoETd6AI4daKMCFR59uYLRgbqWn3dYupLhaTP6gWfYVTydEeYbqB0DlRr9acLGXgY-qrshlni-XbjP6XAwc7ZD5i8MfGWwvOvPT1SDCcR9sBfwur8bEJDg4srSKJ1WEoPEdAY3SBU=\" rel=\"nofollow\" target=\"_blank\">www.praxismedicines.com<\/a>\u00a0and follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=23wwUW7pWhhY0f08fH0KtBLkzu4WXMiQzXees-y7qFza94zVKTL4sWl_dCYtyh-0a6eoSd99y_AV9CQM9wfQy0_uausegoc7EjZ5Ic3t2Q8ppiud6pzMKw2_mo79_uXN4yAzcsE9N_tg394TJgFkZPIzz8FSf2AsA2gY75V5P1JR7FzD0CO3_IluzEgx1EQXnO0HBDAHbby_x_xlaKyUrg8ar4QstkVKGKd8h55cW7z302WQCPM2C2hKrdDzA8v3e3qdb-4i3oFrB8-lqIwSgJCbTGYaFMN5nGi0zYi1WE-zVcwr9W2dbhGTx1ghDOzqVClb572A1PZ9m93FfYUOatbMez4EwneP3c7i6oijfOOH_dKSe7bh3K3hJzVOXtNTH-ey-Wexp0G1t1nOxrXw1csD5vIP_EJXk4oAVPLUn-T-AZfez1LQqMk_dnJiEZE1N19Xr33mWGsFd-p17uduS5NlLjjP4-se8AqYYrRTUimx8GfoyxhmZ3PZB0Y9XbY_IigBj6GVUTpF9xKDdX54YPiAwfcvk2HDQXwSot2e8swmVLoIXVzoowBExPZSDD4jsLxxYNxSAtWXHnCiYNgoeNIRgC_2wzyueq44DGAPccNVx3P-pbPZ2jN8hkGnkCMBPskqN3aAZmK0fdsBCDfx1RrTYi17dAxUZifHQ3LjRFoOvtus0mh4MXTi8XDs6wKeBIZY8fXISItBhAPeBmNt5_19sHKQDYgss8pTq1Bvy9HT_8hs-HCTIifmVqgX3yNe\" rel=\"nofollow\" target=\"_blank\">Facebook<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=j-kEhGVRX6EZxUyrL9UzE37hiECOXUyp15efOA3W47ASucUfNk_6-ZgV7eUpwAM4MEFFZBw53RtCs7lMbnWj7IddOklBVF9NVeZXcxf9S3wuCX2sbtzA2eCwHo-dUpZ2ZfvOgtUmZlvLAbLNc1hRkBkF91TbczeNoQgG3VGByHuGtbTFp3vTQOAqVNxSejcrD6t9WD_II91MI0e89efA1NnyrfhQSFZXlhZA97wZfIjELBSKaQL5H3c1-X6Nhl7TMWalO1NTGkf071YWZor-PkQq4sTLz9DwPDxKd1Q6TfR7e_oB5tD8JNr-W6L8mhFjII2Ze1DHzevlPOmb4eqNY1s0aB9wQQteAeVN2iWf-7h66kF08i1VX3yRF5S-cG4YH484dAGH5ek_5HdcRm8HzgfPxuCEUmmsjp7_nQsaa0F5gwBYamC2mzEP213i_VEZ\" rel=\"nofollow\" target=\"_blank\">Instagram<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QlSRlHyNU00l-JSxWm92KIbRXYXKJntHCsviSI1oe1x3DbBZZvSGuZaHzJTzgLlHytBCBc-rz2u5ijN-Smva0KCPUWQdcKO_ftS9xGW1QBhl5arosId6wM9Wzzfp0qvs05MdawInCHwHJ6S4bEyYk6s6VKnTcdA1FMv4-HTH0JxirPIL0oCCHhKnOQA2avQ3O3bqS35uRadpBpxk786Uk2SfCdlc-eN6lfB5Qo8ijLzM3q4aN-ilBvHW7ktDY0bkc-blsUt1QlfbB3EWyOIIOFTApJFQpNVM-4KwwiDAJTPwZUjyZEXHeore99wtsx7ZLC5MH0oIIdCje_lzetDvazIgz22uU-vBAoqC23KCjH8wSmXw65sVpXDYuRteWMrqDVs0_fjaZJncdCcbr3zCH7aE_aTvha6rz_EMsIlcQnegzDFP2Gf0VNvmLUj9gg-JeZVihZI9prFzZE-_3M3aT73cUNxMqNHG0EMSf-S1oQ10MlzqrRwzihmMljjAsQ4h_-fXHG2CLqnQuq3EOObiw2RpP90YRieYpJm5_f-ZlUzLgWpNjv49IeRBkldnRq1gZyfXgfKDjt43q9Ca_h6UWargRmSGloQtVhPEGBLI0EudJg0g9CqqLsWtirbOdtdy_mC9rmi-flXqk0jEnriVFr4Ic6cdirXcKIvSvdfn3eGTWgjMTqcy5NkMdhsUmOpL45SI7hccySOo2nlDBaXET-1xOjMoRQfX4GlaZkej9uSCydeOATrmV4tHHXDRr3oGSnd3VJuRuH2qSdv9cgap1oOXFEu9pmYSCo_wNvWmsHtFXUSr0WzxDaFQfxHd-hol\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XKa8s1T-cEx5mp_993lJuBHr0TtVIH5EnYsugeqfMbaWczCYnn5dI43AYyyygsi0LnFH-f6-lZVHw1N092lYipXDT2IKlbcm61WfYV59NvRgB8IJoRqhKdcc5UJEqxf4Rsm38n2lcRFe3bkYUguqnCEE94wuqitYMTvVG1oWYM3ROb45D7uT8hTzTQOjwk0ZocP06O6B8G-V7JK10ZNiO84SsbISRUbVlaluWQ-njb9IJmxsAqu_AyMW8CjQOAM0Uu_2SMfbV9Mr__n8k-uGSCC-VGStFftwiCzAe65HuPrjd-Nbb2TguN_8zdiwn4iH1LRSzVpvMQL8gebQAPfVtcEU27wrd6eXQUyCDcz2cGDtsXXgzZySvKFfsocEFkofbO2zhIGc1N7yRpV9qJtuCNO4i1I_V5KL3Kb0MUfLxkBAdByl3GfGzl9cgUm9dyN7nLkYAGlBLw8mkjU1aTFBhUSIh2ovrLVrqFMS4ryEYfjFsrz7gTGhbnHlxQ7ZKvISy1jJ3q5AHMxZ3vxrGShBV1U9djJOu-uTOpTtK2KVojhSF4sVoOMSYszIfq6uhLuhoHOCpJCIiO3X5oiFVhvOi90_e02FWUuPdRKtWyejAeju4IBPGx-HvI-O_kZ7oGc2Bgw-4U2Wa1Rli0JmB6qvrFt4mIJHe0AxKjwBxAFdlfT6NvqGJN0Zy0GYBBzU77Vk\" rel=\"nofollow\" target=\"_blank\">Twitter\/X<\/a>.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyMzYyOCM3MTMwNjk4IzIyMDA4OTY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YWZkZWI4YTctNWU1MS00Yzc1LWJhY2ItOTA4Zjc0NjY3MjUxLTEyMTI0NDktMjAyNS0wOS0wNC1lbg==\/tiny\/Praxis-Precision-Medicines-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Investor Contact:\u00a0\r\nPraxis Precision Medicines\u00a0\r\ninvestors@praxismedicines.com\u00a0\r\n857-702-9452\u00a0\r\n\u00a0\r\nMedia Contact:\r\nDan Ferry\r\nLife Science Advisors\r\nDaniel@lifesciadvisors.com\r\n617-430-7576<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, Mass., Sept. 04, 2025 (GLOBE NEWSWIRE) &#8212; Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that Praxis\u2019 management will be attending and presenting in three upcoming investor conferences: Baird 2025 Global Healthcare Conference: a corporate presentation will take place on Tuesday, September 9th at 9:00-9:35am EDT at the InterContinental New York Barclay. H.C. Wainwright 27th Annual Global Investment Conference: a fireside chat will be held on Wednesday, September 10th at 8:30am EDT at the Lotte New York Palace Hotel in New York City. A live webcast of the fireside chat will be available through this link. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-september-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Praxis Precision Medicines to Participate in September Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-882133","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Praxis Precision Medicines to Participate in September Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-september-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Praxis Precision Medicines to Participate in September Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, Mass., Sept. 04, 2025 (GLOBE NEWSWIRE) &#8212; Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that Praxis\u2019 management will be attending and presenting in three upcoming investor conferences: Baird 2025 Global Healthcare Conference: a corporate presentation will take place on Tuesday, September 9th at 9:00-9:35am EDT at the InterContinental New York Barclay. H.C. Wainwright 27th Annual Global Investment Conference: a fireside chat will be held on Wednesday, September 10th at 8:30am EDT at the Lotte New York Palace Hotel in New York City. A live webcast of the fireside chat will be available through this link. &hellip; Continue reading &quot;Praxis Precision Medicines to Participate in September Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-september-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-04T20:30:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyMzYyOCM3MTMwNjk4IzIyMDA4OTY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-september-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-september-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Praxis Precision Medicines to Participate in September Investor Conferences\",\"datePublished\":\"2025-09-04T20:30:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-september-investor-conferences\\\/\"},\"wordCount\":314,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-september-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUyMzYyOCM3MTMwNjk4IzIyMDA4OTY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-september-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-september-investor-conferences\\\/\",\"name\":\"Praxis Precision Medicines to Participate in September Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-september-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-september-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUyMzYyOCM3MTMwNjk4IzIyMDA4OTY=\",\"datePublished\":\"2025-09-04T20:30:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-september-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-september-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-september-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUyMzYyOCM3MTMwNjk4IzIyMDA4OTY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUyMzYyOCM3MTMwNjk4IzIyMDA4OTY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-september-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Praxis Precision Medicines to Participate in September Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Praxis Precision Medicines to Participate in September Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-september-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Praxis Precision Medicines to Participate in September Investor Conferences - Market Newsdesk","og_description":"BOSTON, Mass., Sept. 04, 2025 (GLOBE NEWSWIRE) &#8212; Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that Praxis\u2019 management will be attending and presenting in three upcoming investor conferences: Baird 2025 Global Healthcare Conference: a corporate presentation will take place on Tuesday, September 9th at 9:00-9:35am EDT at the InterContinental New York Barclay. H.C. Wainwright 27th Annual Global Investment Conference: a fireside chat will be held on Wednesday, September 10th at 8:30am EDT at the Lotte New York Palace Hotel in New York City. A live webcast of the fireside chat will be available through this link. &hellip; Continue reading \"Praxis Precision Medicines to Participate in September Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-september-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2025-09-04T20:30:45+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyMzYyOCM3MTMwNjk4IzIyMDA4OTY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-september-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-september-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Praxis Precision Medicines to Participate in September Investor Conferences","datePublished":"2025-09-04T20:30:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-september-investor-conferences\/"},"wordCount":314,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-september-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyMzYyOCM3MTMwNjk4IzIyMDA4OTY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-september-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-september-investor-conferences\/","name":"Praxis Precision Medicines to Participate in September Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-september-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-september-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyMzYyOCM3MTMwNjk4IzIyMDA4OTY=","datePublished":"2025-09-04T20:30:45+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-september-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-september-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-september-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyMzYyOCM3MTMwNjk4IzIyMDA4OTY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyMzYyOCM3MTMwNjk4IzIyMDA4OTY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-september-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Praxis Precision Medicines to Participate in September Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/882133","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=882133"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/882133\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=882133"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=882133"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=882133"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}